Chronic Hepatitis B — REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection
Citation(s)
An Open-label, Randomized, Active Controlled, Parallel Comparison Study of the Safety and Efficacy of REP 2139-Mg in Combination With Pegasys® and Viread® and REP 2165-Mg in Combination With Pegasys® and Viread® in Patients With HBeAg Negative Chronic Hepatitis B